| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |